Product image of Ondaseprol (Ondansetron) supplied by GNH India

Ondaseprol

Active Ingredient:
Ondansetron
Origin:
EU

Ondaseprol (Ondansetron)

Ondansetron, the active ingredient in Ondaseprol, is a 5-HT3 receptor antagonist presented as a  tablet for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiotherapy, and surgery in adult and pediatric patients.

GNH India supplies Ondaseprol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Novendia Pharmaceuticals Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron is used to manage nausea and vomiting by targeting the serotonergic pathways involved in emesis.

  • Chemotherapy‑induced nausea and vomiting: helps prevent and control acute and delayed episodes.
  • Radiotherapy‑induced nausea and vomiting: reduces the frequency and severity of symptoms.
  • Post‑operative nausea and vomiting: decreases incidence after general anesthesia.

How It Works

  • Ondansetron selectively blocks the 5‑hydroxy‑tryptamine type 3 (5‑HT3) receptors located on vagal afferent nerves in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain, inhibiting serotonin‑mediated signaling that initiates the vomiting reflex.

Side Effects

Adverse reactions to ondansetron are generally mild to moderate, but serious events can occur.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Constipation: reduced bowel movements.
  • Diarrhoea: loose stools.
  • Fatigue: feeling of tiredness.
  • Dizziness: light‑headed sensation.
  • Injection site pain (if administered parenterally).

Serious or Rare Side Effects

  • QT interval prolongation: may predispose to cardiac arrhythmias.
  • Severe hypersensitivity: rash, itching, swelling, or anaphylaxis.
  • Serotonin syndrome: agitation, tremor, hyperreflexia when combined with serotonergic agents.
  • Hepatic dysfunction: elevated liver enzymes.
  • Vision changes: blurred vision or visual disturbances.
  • Neuroleptic malignant‑like syndrome: rare but life‑threatening reaction.

Precautions & Warnings

When prescribing ondansetron, clinicians should consider several safety aspects.

  • Cardiac monitoring: patients with known QT prolongation or electrolyte imbalance should be observed.
  • Drug interactions: review concomitant serotonergic or QT‑prolonging medications.
  • Renal impairment: dose adjustment may be required in severe renal dysfunction.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Pregnancy and lactation: assess risk‑benefit ratio before use.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light, retain in original packaging.

Avoid Interactions

Ondansetron may interact with several medicines, requiring vigilance.

Major Interactions (Avoid)

  • Amiodarone: additive risk of QT prolongation.
  • Cisapride: combined effect on cardiac repolarization.
  • Certain anti‑malarial drugs (e.g., quinidine): heightened QT prolongation risk.

Moderate Interactions (Monitor Closely)

  • Serotonergic agents (SSRIs, SNRIs, MAOIs): potential for serotonin syndrome.
  • Antifungal azoles (ketoconazole, fluconazole): may increase ondansetron plasma levels.
  • Macrolide antibiotics (erythromycin, clarithromycin): modest QT effect.
  • Calcium channel blockers (diltiazem, verapamil): may raise drug concentrations.

Frequently Asked Questions

Ondaseprol contains ondansetron, an anti‑emetic that is prescribed to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy and surgical procedures. It is used in both adult and pediatric patients when control of emesis is required.

Ondansetron works by selectively blocking 5‑HT3 receptors in the gastrointestinal tract and the brain’s chemoreceptor trigger zone. This inhibition stops serotonin‑mediated signals that trigger the vomiting reflex, thereby reducing nausea and vomiting.

The dose of Ondaseprol is determined by the prescribing clinician based on the patient’s age, weight, the type of emetogenic stimulus and clinical guidelines. Healthcare professionals set the appropriate regimen for each individual case.

Safety data are limited; ondansetron is classified as Pregnancy Category B in many regions, indicating no evidence of risk in animal studies but insufficient human data. Use only if the potential benefit outweighs any possible risk, and consult a healthcare provider before use while breastfeeding.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ondaseprol (ondansetron) belongs to the 5‑HT3 antagonist class, offering rapid onset and effective control of both acute and delayed chemotherapy‑induced nausea. Compared with dopamine antagonists such as metoclopramide, ondansetron has a lower risk of extrapyramidal side effects and is often preferred for high‑risk emetogenic regimens.

Store Ondaseprol at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct light, and avoid storing them in humid or excessively hot environments.

Ondaseprol is supplied as oral tablets that are taken by mouth with or without water, according to the prescriber’s instructions. In some clinical settings, an injectable formulation may be used, but the tablet form is intended for oral administration.

The most serious risks include QT interval prolongation, which can lead to potentially life‑threatening cardiac arrhythmias, and severe hypersensitivity reactions such as anaphylaxis. Patients should be monitored for cardiac symptoms and any signs of allergic response.

Ondaseprol should be avoided in patients with known hypersensitivity to ondansetron or any component of the formulation, and in individuals with congenital long QT syndrome or a history of significant cardiac arrhythmias unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT